Skip to content

Analysis of liver and kidney microarrays of Ahr-null or wild-type C57BL/6 mice ravaged with TCDD or vehicle.

Notifications You must be signed in to change notification settings

WarrenSink/BoutrosMicroarrays

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

5 Commits
 
 
 
 
 
 
 
 
 
 

Repository files navigation

Analysis of liver and kidney microarrays of Ahr-null or wild-type C57BL/6 mice ravaged with TCDD or vehicle

This repo contains my reproduction of the liver and kidney Affymetrix microarray analysis found in the paper by Boutros et al, 2009 [1].

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a "forever" chemical and byproduct of industrial chemical synthesis and incomplete combustion. As described in Boutros et al., C57BL/6 mice with or without a knocked-out Ahr (Ahr-null or wild-type, respectively) were gavaged with 1000 µg/kg TCDD or vehicle. 19 hours later, the mice were sacrificed and their liver and kidneys were harvested. Although the authors say in their Methods the livers and kidneys were collected from the same mice, I was not able to find animal identifiers, indicating if a liver microarray from a certain mouse matched to a kidney microarray and vice versa.

Firstly, for determining differential expression, the liver and kidney data were considered separately. Then, considering all samples from each tissue, a general linear model was fitted using the R package limma[2]:

$$Y = Basal + AhR + TCDD + AhR:TCDD$$

Where $Y$ refers to a ProbeSet's expression level, $Basal$ refers to the basal gene expression of a ProbeSet, $AhR$ refers to the animal's Ahr genotype, and $TCDD$ refers to whether the animals was gavaged with 1000 µg/kg TCDD or vehicle. The final term, $AhR:TCDD$, refers to an effect on a ProbeSet's expression level explained by the interaction of TCDD and AhR, which makes sense since TCDD selectively binds and activates the AhR, promoting gene regulation. The linear model was fit separately for each organ's 45,101 unique ProbeSets and for each organ, kidney and liver. After fitting the model to each Probeset, each coefficient's p-value (for $AhR$, $TCDD$, and $AhR:TCDD$) were adjusted by the Benjamanini-Hochberg False Discovery Ratio method. This contrasts with their cited Bayesian-FDR method. Although this leads to differences in the exact number of significantly regulated ProbeSets in the liver and kidney as as response to Ahr genotype or TCDD-AhR interactions, my non-Bayesian approach produces roughly similar results.

In the R Markdown folder, the html output from knitting the Rmd file may be opened in your browser of choice. The analysis is mostly un-novel and is meant to follow the figures and tables in the Boutros et al. paper, except for the functional enrichment analysis of subsets of unique differential Gene Symbols (Gene Symbols are 1:n with ProbeSets).

Upcoming Analysis:

  • PLIER?

References

[1] Boutros, P. C., Bielefeld, K. A., Pohjanvirta, R. & Harper, P. A. (2009) "Dioxin-dependent and dioxin-independent gene batteries: Comparison of liver and kidney in AHR-null mice." Toxicol. Sci. 112, 245–256. doi: 10.1093/toxsci/kfp191.

[2] Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015). “limma powers differential expression analyses for RNA-sequencing and microarray studies.” Nucleic Acids Research, 43(7), e47. doi: 10.1093/nar/gkv007.

About

Analysis of liver and kidney microarrays of Ahr-null or wild-type C57BL/6 mice ravaged with TCDD or vehicle.

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published